US Transgenic Animals Market

ID: MRFR/LS/18517-HCR
100 Pages
Vikita Thakur
Last Updated: April 06, 2026
US Transgenic Animals Market Research Report By Products (Gene Gun, Microinjection) - Growth & Industry Forecast 2025 To 2035
US Transgenic Animals Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)10.48%
2024 Market Size$ 996.8 Million
2025 Market Size$ 1,101.26 Million
2035 Market Size$ 2,983.51 Million
Key Players
Heska Corporation
Genus plc
AquaBounty Technologies
Inc.
Transgene SA
Recombinetics
Opportunities
  • Advancements in Biotechnology
  • Increasing Focus on Food Security
  • Investment in Research and Development
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Security, Access Control and Robotics, BY Type (USD Million)
      1. 4.1.1 OCR gene gun
      2. 4.1.2 microinjections
      3. 4.1.3 electroporator
    2. 4.2 Security, Access Control and Robotics, BY Techniques (USD Million)
      1. 4.2.1 retro-virus-mediated transfer of gene
      2. 4.2.2 embryonic stem cell-mediated transfer of gene
      3. 4.2.3 microinjection of DNA
    3. 4.3 Security, Access Control and Robotics, BY Applications (USD Million)
      1. 4.3.1 recombinant human proteins
      2. 4.3.2 monoclonal antibodies
      3. 4.3.3 xenotransplantation
    4. 4.4 Security, Access Control and Robotics, BY Model Organisms (USD Million)
    5. 4.5 Security, Access Control and Robotics, BY End-Users (USD Million)
      1. 4.5.1 biotechnological industry
      2. 4.5.2 research organizations
      3. 4.5.3 academic institutes
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Heska Corporation (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Genus plc (GB)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 AquaBounty Technologies, Inc. (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Transgene SA (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Recombinetics, Inc. (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 InVivo Therapeutics Holdings Corp. (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Ceres, Inc. (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Envigo (GB)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY TECHNIQUES
    4. 6.4 US MARKET ANALYSIS BY APPLICATIONS
    5. 6.5 US MARKET ANALYSIS BY MODEL ORGANISMS
    6. 6.6 US MARKET ANALYSIS BY END-USERS
    7. 6.7 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
    10. 6.10 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
    12. 6.12 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
    13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE, 2024 (% SHARE)
    14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TECHNIQUES, 2024 (% SHARE)
    16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TECHNIQUES, 2024 TO 2035 (USD Million)
    17. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATIONS, 2024 (% SHARE)
    18. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATIONS, 2024 TO 2035 (USD Million)
    19. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY MODEL ORGANISMS, 2024 (% SHARE)
    20. 6.20 SECURITY, ACCESS CONTROL AND ROBOTICS, BY MODEL ORGANISMS, 2024 TO 2035 (USD Million)
    21. 6.21 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USERS, 2024 (% SHARE)
    22. 6.22 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USERS, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY TECHNIQUES, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATIONS, 2025-2035 (USD Million)
      4. 7.2.4 BY MODEL ORGANISMS, 2025-2035 (USD Million)
      5. 7.2.5 BY END-USERS, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Transgenic Animals Market Segmentation

US Transgenic Animals Market By Type (USD Million, 2025-2035)

  • OCR gene gun
  • microinjections
  • electroporator

US Transgenic Animals Market By Techniques (USD Million, 2025-2035)

  • retro-virus-mediated transfer of gene
  • embryonic stem cell-mediated transfer of gene
  • microinjection of DNA

US Transgenic Animals Market By Applications (USD Million, 2025-2035)

  • recombinant human proteins
  • monoclonal antibodies
  • xenotransplantation

US Transgenic Animals Market By Model Organisms (USD Million, 2025-2035)

    US Transgenic Animals Market By End-Users (USD Million, 2025-2035)

    • biotechnological industry
    • research organizations
    • academic institutes
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.